GET THE APP

Immunotherapy: Open Access
Open Access

ISSN: 2471-9552

+44 1223 790975

Immunotherapy: Open Access : Citations & Metrics Report

Articles published in Immunotherapy: Open Access have been cited by esteemed scholars and scientists all around the world. Immunotherapy: Open Access has got h-index 6, which means every article in Immunotherapy: Open Access has got 6 average citations.

Following are the list of articles that have cited the articles published in Immunotherapy: Open Access.

	2021	2020	2019	2018	2017
Year wise published articles	32	11	4	5	15
Year wise citations received	26	13	13	17	22

Journal total citations count	151
Journal impact factor	0.77
Journal 5 years impact factor	1.13
Journal cite score	1.32
Journal h-index	6
Journal h-index since 2018	5

Important citations (68)

Targeted delivery of il-12 adjuvants immunotherapy by oncolytic viruses View at Publisher View at Google Scholar View at Indexing
Delivery of cancer therapies by synthetic and bio-inspired nanovectors View at Publisher View at Google Scholar View at Indexing
Cytokines in oncolytic virotherapy View at Publisher View at Google Scholar View at Indexing
Oncolytic virus encoding a master pro-inflammatory cytokine interleukin 12 in cancer immunotherapy View at Publisher View at Google Scholar View at Indexing
Design, synthesis and biological activity of peptide vectors for cancer targeting and / or therapy View at Publisher View at Google Scholar View at Indexing
Monoklonini? ir rekombinantini? antik?n? prieš karboanhidrazes k?rimas View at Publisher View at Google Scholar View at Indexing
Imaging in tumor immunology View at Publisher View at Google Scholar View at Indexing
Targeting the ether-à-go-go ion channels in cancer therapy: current knowledge and future perspectives View at Publisher View at Google Scholar View at Indexing
Targeting and pharmacology of an anti-il13r?2 antibody and antibody-drug conjugate in a melanoma xenograft model View at Publisher View at Google Scholar View at Indexing
Say no to drugs: bioactive macromolecular therapeutics without conventional drugs View at Publisher View at Google Scholar View at Indexing
Conservation of oncofetal antigens on human embryonic stem cells enables discovery of monoclonal antibodies against cancer View at Publisher View at Google Scholar View at Indexing
Cytokine?induced killer cells/natural killer cells combined with anti?gd2 monoclonal antibody increase cell death rate in neuroblastoma sk?n?sh cells View at Publisher View at Google Scholar View at Indexing
Opportunities for antibody discovery using human pluripotent stem cells: conservation of oncofetal targets View at Publisher View at Google Scholar View at Indexing
Targeting tumor vascular cd99 inhibits tumor growth View at Publisher View at Google Scholar View at Indexing
In vivo imaging technologies to monitor the immune system View at Publisher View at Google Scholar View at Indexing
Cd-340 functionalized doxorubicin-loaded nanoparticle induces apoptosis and reduces tumor volume along with drug-related cardiotoxicity in mice View at Publisher View at Google Scholar View at Indexing
Targeting tumor vascular cd99 inhibits tumor growth View at Publisher View at Google Scholar View at Indexing
Concepts for agonistic targeting of cd40 in immuno-oncology View at Publisher View at Google Scholar View at Indexing
Retargeting lentiviruses via spycatcher-spytag chemistry for gene delivery into specific cell types View at Publisher View at Google Scholar View at Indexing
Retargeting lentiviruses via spycatcher-spytag chemistry for gene delivery into specific cell types View at Publisher View at Google Scholar View at Indexing
Prev 1 2 3 4 Next »

Top